|
Model Number B35200 |
Device Problems
Malposition of Device (2616); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bacterial Infection (1735); Erythema (1840); Pocket Erosion (2013); Discomfort (2330); Swelling/ Edema (4577)
|
Event Date 04/01/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Other medical products in use during the event include: brand name ; product id: neu_unknown_ext (serial: unknown); product type: 0191-extension; implant date: (b)(6) 2023, brand name: lead.Product id: neu_unknown_lead (serial: unknown); product type: 0200-lead; implant date: (b)(6) 2023.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
It was reported that the patient mentioned the stimulator was uncomfortable.The neurosurgeon saw that the stimulator was covered with only a small layer of skin.The skin also looked a little red.A surgery was needed to put the stimulator deeper on (b)(6) 2023.The cause was either a low grade infection or the stimulator had worked its way to just under the skin/eroded.After the operation, on (b)(6) 2023, the wound was again swollen and red.The neurosurgeon took fluid with a syringe.Optic, it seemed to be old blood.Culture seemed to be staphylococcus epidermidis.The stimulator and extension were removed and not replaced on (b)(6) 2023.On (b)(6) 2023, the patient had swollen wound above leads.Culture was taken and also showed staph epidermidis.The leads were removed on (b)(6) 2023.The event also resulted in hospitalization.The issue was resolved without sequelae.
|
|
Manufacturer Narrative
|
Concomitant medical products: product id :37085-95, serial# (b)(6), implanted: (b)(6)2011, explanted: (b)(6) 2023, product type extension.Product id 3389-28, lot# 0205464409, implanted: (b)(6) 2011, explanted: (b)(6) 2023, product type lead.Product id 37085-95, lot#/serial# (b)(6) implanted: (b)(6) 2011, explanted: (b)(6) 2023, product type extension.Product id 3389-28, lot# 0205464408, implanted: (b)(6) 2011, explanted: (b)(6) 2023, product type lead.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|